Vident Investment Advisory, LLC Eli Lilly & CO Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $381,955 - $510,719	-1,089 Reduced 2.6%	40,822 $19.1 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $4.29 Million - $5.03 Million	13,798 Added 49.08%	41,911 $14.4 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $6.86 Million - $7.99 Million	21,326 Added 314.22%	28,113 $10.3 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $533,367 - $607,828	1,799 Added 36.07%	6,787 $899,000
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $1.14 Million - $1.33 Million	-4,074 Reduced 44.96%	4,988 $1.62 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $2.49 Million - $3.09 Million	-10,604 Reduced 53.92%	9,062 $2.59 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $1.66 Million - $2.06 Million	7,371 Added 59.95%	19,666 $5.43 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $1.48 Million - $1.82 Million	-6,664 Reduced 35.15%	12,295 $2.84 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $865,556 - $1.12 Million	4,794 Added 33.84%	18,959 $4.35 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $647,913 - $838,754	3,943 Added 38.57%	14,165 $2.65 Million
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $108,151 - $143,110	-829 Reduced 7.5%	10,222 $1.73 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $205,731 - $237,965	1,407 Added 14.59%	11,051 $1.64 Million
Q2 2020 Jul 28, 2020	SELL	$136.42 - $164.18 $3.96 Million - $4.77 Million	-29,039 Reduced 75.07%	9,644 $1.58 Million
Q2 2020 Jul 17, 2020	BUY	$136.42 - $164.18 $3.87 Million - $4.65 Million	28,340 Added 274.0%	38,683 $6.35 Million
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $366,435 - $453,543	3,078 Added 42.37%	10,343 $1.44 Million
Q4 2019 Feb 11, 2020	SELL	$106.92 - $132.43 $74,630 - $92,436	-698 Reduced 8.77%	7,265 $955,000
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $24,454 - $26,600	229 Added 2.96%	7,963 $891,000
Q2 2019 Aug 12, 2019	BUY	$110.79 - $129.32 $76,001 - $88,713	686 Added 9.73%	7,734 $857,000
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $207,036 - $243,697	-1,860 Reduced 20.88%	7,048 $914,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $71,906 - $80,556	679 Added 8.25%	8,908 $1.03 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $215,594 - $269,455	-2,511 Reduced 23.38%	8,229 $883,000
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $95,079 - $109,121	-1,256 Reduced 10.47%	10,740 $917,000
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $17,884 - $21,111	241 Added 2.05%	11,996 $961,000
Q4 2017 Feb 15, 2018	SELL	$81.94 - $87.89 $242,296 - $259,890	-2,957 Reduced 20.1%	11,755 $992,000
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $1.13 Million - $1.26 Million	14,712	14,712 $1.26 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$72.5 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$55.2 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$49.3 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$38.4 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$25.3 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account